Toll-Like Receptor Signaling in Innate Immune Responses

Toll-like receptors (TLRs) constitute a family of pattern-recognition receptors expressed by innate immune cells that detect conserved molecular signatures from pathogens. Upon engagement of their extracellular or endosomal domains by microbial components—such as lipopolysaccharide, peptidoglycan, viral RNA or unmethylated CpG DNA—TLRs undergo conformational changes that promote recruitment of cytosolic adaptor proteins. Two principal adaptor pathways are defined by MyD88 and TRIF, which initiate cascades culminating in activation of transcription factors NF-κB, AP-1 and interferon regulatory factors. These events drive production of inflammatory cytokines, chemokines and type I interferons, shaping downstream adaptive responses and establishing antimicrobial defences.

Tight control of TLR signalling is achieved by multiple regulatory checkpoints, including receptor trafficking, post-translational modifications and assembly of adaptor complexes such as the Myddosome. Dysregulation of these processes contributes to inflammatory and autoimmune disorders, sepsis and impaired antiviral immunity. Owing to their central role in host defence, TLRs are the focus of intense research aimed at discovering modulators that can serve as vaccine adjuvants, anti-infective agents or treatments for chronic inflammation.

Research from Nature Portfolio

High-resolution structural analyses have revealed that Toll-like receptor 3 forms extended multimeric assemblies along long double-stranded RNA ligands. Cryo-electron microscopy demonstrates that lateral interactions between TLR3 dimers facilitate cooperative binding to viral RNA, thereby enhancing signal transduction efficiency and antiviral cytokine induction. This mechanism underscores the importance of ligand length in receptor activation and suggests avenues for designing synthetic RNA-based agonists. In parallel, small-molecule studies have identified a natural flavonoid derivative that binds to the extracellular domain of TLR4, inhibiting downstream IKK and MAPK activation and promoting Nrf2-mediated antioxidant responses. This compound dampens pro-inflammatory cytokine release, reduces reactive oxygen species and protects against endotoxin-induced injury in macrophage models, illustrating the therapeutic potential of direct TLR modulation.

Toll-Like Receptor Signaling in Innate Immune Responses publication trend

The graph below shows the total number of articles in toll-like receptor signaling in innate immune responses across all publications each year (not limited to Nature Index journals).

Technical terms

Toll-like receptor (TLR): A membrane-bound sensor of pathogen-associated molecular patterns.
Adaptor molecule: A cytosolic protein that links activated TLRs to downstream kinases.
Myddosome: A multiprotein complex centred on MyD88 and IRAK kinases that initiates inflammatory signalling.
dsRNA: Double-stranded RNA, a viral ligand recognised by endosomal TLR3.
Ubiquitination: The covalent attachment of ubiquitin to target proteins, modulating their function or fate.
NF-κB: A transcription factor central to inflammatory and immune gene expression.
TIR domain: Toll/interleukin-1 receptor homology region mediating adaptor recruitment and signal propagation.

References

1. Toll-Like Receptor Signaling Pathways. Frontiers in Immunology (2014).
2. TLR3 forms a laterally aligned multimeric complex along double-stranded RNA for efficient signal transduction. Nature Communications (2023).
3. OTUD5 promotes the inflammatory immune response by enhancing MyD88 oligomerization and Myddosome formation. Cell Death & Differentiation (2024).
4. Massively Parallel Screening of Toll/Interleukin‐1 Receptor (TIR)‐Derived Peptides Reveals Multiple Toll‐Like Receptors (TLRs)‐Targeting Immunomodulatory Peptides. Advanced Science (2024).
5. Procyanidin A1 Alleviates Inflammatory Response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 Pathways in RAW264.7 cells. Scientific Reports (2019).